| Financial Year |
March 31 2023 |
| Monetary Funds |
1,951,836,649.55 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,415,835.65 |
| Accounts Receivable |
446,356,470.31 |
| Advances to Suppliers |
46,350,554.82 |
| Other Receivables |
140,352,713.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
206,874,007.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
196,502,118.69 |
| Total Current Assets |
2,990,688,349.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
12,536,382.24 |
| Investment Properties |
-- |
| Fixed Assetes |
103,037,384.01 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,820,323.89 |
| R&D expenses |
-- |
| Goodwill |
695,383,940.08 |
| Long-Term Deferred and Prepaid Expenses |
11,052,753.24 |
| Deferred Income Tax Assets |
35,151,102.63 |
| Other Non-Current Assets |
1,639,040.00 |
| Sub-Total of Non-Current Assets |
987,719,510.30 |
| Total Assets |
3,978,407,860.17 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
80,579,271.23 |
| Accounts Payable |
330,634,535.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
92,002,228.84 |
| Taxes Payable |
19,255,400.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
309,670,743.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,038,431.78 |
| Other Current Liabilities |
2,601,614.35 |
| Sub-Total of Current Liabilities |
954,044,896.67 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
35,880,311.79 |
| Deferred Income Tax Liabilities |
207,683.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
54,097,914.24 |
| Total Liabilities |
1,008,142,810.91 |
| Paid-In Capital(Or Share Stock) |
506,559,257.00 |
| Capital Surplus |
1,252,216,038.98 |
| Surplus Reserve |
117,427,016.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,069,350,893.14 |
| Minority Stockholder's Interest |
18,633,514.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,951,631,534.43 |
| Owner's Equity（Stockholder's Equity） |
2,970,265,049.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,978,407,860.17 |
